Abraxis Pharmaceutical Products
Keywords: research, industry, outlook, company, profiles, market, analysis, trends
Full Report Price:
0.00
Delivery: Immediate Online Access
Publication Date: 29-MAY-07
Pages: 1
Format:
|
 |
Report DescriptionAbraxis received two approvals from the FDA for its Abbreviated New Drug Applications (ANDAs) for Clindamycin Injection, 300mg, 600mg, 900mg and 9g, USP, the generic equivalent of Pfizer's Cleocin® Phosphate Injection. |
|
|
|
Knowledge Source Research Products |
|
Browse other Knowledge Source industry research products:
Health Care Market Overviews
BusIntell Reports
Spotlight
|
About Knowledge Source |
|
Knowledge Source On-Line, since 1989, has delivered healthcare business information and analyses services to executives who seek a competitive edge. Knowledge Source provides healthcare information, syntheses, analysis and presentation services to busy managers who seek actionable market knowledge about clients, competitors, industries or markets in a world with an over-abundance of data. |
|
|
|
|
